Acute treatment of mice with tunicamycin, an experimental model for the short-term induction of hepatosteatosis and NAFLD [17], caused significant upregulation of Armcx3 mRNA and ARMCX3 protein in liver. Here, ARMCX3 is linked to metabolic dysfunction-associated steatotic liver disease.